Beijing Bridge Biopharmaceutical

Beijing Bridge Biopharmaceutical is a clinical-stage biotechnology company based in Beijing, China, focused on the discovery and development of innovative therapies for oncology and other unmet medical needs. The company leverages its internal R&D capabilities to advance a pipeline of small molecule inhibitors and biologics targeting well-validated pathways in cancer biology. Its lead programs are currently in mid-stage clinical trials, aiming to provide more effective treatment options for patients with solid tumors and hematological malignancies. Beijing Bridge Biopharmaceutical emphasizes strategic collaborations and a robust intellectual property portfolio to drive its growth in the competitive Chinese and global biopharmaceutical markets.